# Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).

> **NCT05211193** · — · COMPLETED · sponsor: **Stimvia s.r.o.** · enrollment: 40 (actual)

## Conditions studied

- Overactive Bladder (OAB)
- Failed Any OAB Pharmacotherapy

## Interventions

- **DEVICE:** eTNM delivered by URIS I nerve stimulation device

## Key facts

- **NCT ID:** NCT05211193
- **Lead sponsor:** Stimvia s.r.o.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-08
- **Primary completion:** 2020-04-28
- **Final completion:** 2020-11-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05211193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05211193, "Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05211193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*